Categories: Inova in the NewsITMI

Personalized medicine could mean big business for D.C.-area companies, The Washington Post, May 31, 2015

The American health-care industry’s pivot to personalized medicine has attracted the interest of an unlikely group of companies — government contractors.

As health-care providers explore this new model of treatment, which involves the study of the human genome to provide personalized care, they face a problem with which many in government are familiar: analyzing an overwhelming amount of data. Read more.

InovaNewsroom

Share
Published by
InovaNewsroom
Tags: ICPH

Recent Posts

The most important heart disease risk test you’ve never heard of

What is hsCRP, and how can it help predict your risk of developing heart disease?…

3 days ago

Inova continues to set the national standard for excellence in health care

Recognition from U.S. News & World Report, Modern Healthcare and Press Ganey highlights Inova's commitment…

2 weeks ago

Inova appoints Susan Carroll as Chief, Clinical Enterprise Operations   

Raj Chand, MD, to serve as Interim President, Inova Loudoun Hospital  Fairfax, VA — Inova is pleased to announce…

2 weeks ago

Inova first in Virginia and Mid-Atlantic to use advanced fluorescent imaging technology to improve ovarian cancer surgery

FDA-approved technology helps surgeons visualize ovarian cancer in real time during surgery FAIRFAX, Va. –…

3 weeks ago

Inova Loudoun Mobile Health Services: August 2026

Leesburg, VA — Inova Loudoun Hospital Mobile Health Services will be providing countywide blood pressure…

3 weeks ago

Inova Schar Cancer’s pulmonary nodule program saves lives

Study at a glanceInova’s incidental lung nodule program has shown a 76% reduction in time…

4 weeks ago